COMMUNIQUÉS West-GlobeNewswire

Bellerophon Announces Results of Interim Analysis of Phase 3 INOvation-1 Study Evaluating INOpulse® for Treatment of Pulmonary Arterial Hypertension

07/08/2018 - 14:30

WARREN, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that the Data Monitoring Committee [...]

Viveve Announces FDA Approval to Continue VIVEVE II Clinical Study

07/08/2018 - 14:28

Agency determines one-month safety data sufficient in first-stage and grants continued enrollment of up to 100 subjects in second stage of sexual function trial ENGLEWOOD, Colo., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Viveve [...]

Achroma Corp. Announces Global Survey Results of 226 People with Achromatopsia

07/08/2018 - 14:00

More than One-Third of People with Achromatopsia Were Misdiagnosed with Retinal or Cone Dystrophy Only 58% of Adults and 65% of Children with Achromatopsia Have Received Genetic Testing BUTLER, Pa., Aug. 07, 2018 (GLOBE [...]

Onconova Therapeutics, Inc. to Provide Corporate Update and Second Quarter 2018 Financial Results

07/08/2018 - 14:00

Company to Hold Conference Call and Webcast at 9:00 a.m. Eastern Time on Tuesday August 14, 2018 NEWTOWN, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage [...]

Proteon Therapeutics Announces Second Quarter 2018 Financial Results

07/08/2018 - 14:00

WALTHAM, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]

Allena Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update

07/08/2018 - 14:00

- Enrolling Global Phase 3 URIROX-1™ Trial; Plan to Initiate URIROX-2™ in 2H18 - - Treated First Patients in Phase 2 Basket Study of Reloxiliase (ALLN-177) for Primary Hyperoxaluria or Enteric Hyperoxaluria with [...]

Rexahn Issues Mid-Year Shareholder Letter to Review Recent Progress and Clinical Plans

07/08/2018 - 14:00

ROCKVILLE, Md., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, [...]

Teneobio and Poseida Expand Their Partnership to Develop UniDabs™ for Advanced CAR-T Therapies

07/08/2018 - 14:00

MENLO PARK, Calif. and SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Teneobio, Inc., a next generation multi-specific antibody therapeutics company, and Poseida Therapeutics, Inc., a San Diego-based clinical-stage [...]

UroGen Pharma to Report Second Quarter 2018 Financial Results on Tuesday, August 14, 2018

07/08/2018 - 14:00

Conference Call and Webcast Scheduled for 8:30 AM ET RA’ANANA, Israel and NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ:URGN) today announced that it will report second quarter 2018 financial [...]

Progressive Care to Host Conference Call on Second Quarter 2018 Financial Results and Business Update on Aug. 14

07/08/2018 - 14:00

MIAMI, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that the company will host a conference call on Tuesday, Aug. 14 [...]

Avivagen Announces Agreement to Terminate China JV

07/08/2018 - 14:00

OTTAWA, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and [...]

Establishment Labs to Release Second Quarter 2018 Financial Results on August 14, 2018

07/08/2018 - 14:00

NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Establishment Labs (NASDAQ: ESTA) today announced that the Company will release its second quarter 2018 financial results on Tuesday, August 14, 2018, prior to the open of U.S [...]

Altimmune to Announce Second Quarter 2018 Financial Results on August 15

07/08/2018 - 14:00

GAITHERSBURG, Md., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced that it will announce financial results for the quarter and year ended [...]

CLS Holdings USA Closes $3 Million Investment from Navy Capital

07/08/2018 - 14:00

Growth Equity Capital from Leading Cannabis Focused Institution LAS VEGAS, Aug. 07, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences [...]

TACTI-mel Patient Recruitment Complete and Operational Update

07/08/2018 - 14:00

Patient recruitment completed for Part B of ongoing TACTI-mel Phase I clinical trial Progress on Immutep’s TACTI-002 and AIPAC GSK nominates ulcerative colitis as its lead indication for IMP731 ( GSK2831781 ) Novartis [...]

iCAD to Report Second Quarter and Six Months Ended June 30, 2018 Financial Results on Tuesday, August 14th

07/08/2018 - 14:00

NASHUA, N.H., Aug. 07, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of [...]

Novo Nordisk A/S - Share repurchase programme

07/08/2018 - 13:45

Bagsværd, Denmark, 7 August 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]

Radius Health Reports Second Quarter 2018 Financial and Operating Results and Provides Business Update

07/08/2018 - 13:45

Second quarter 2018 TYMLOS sales increase to $22.6 million, a 56% increase over the first quarter of 2018 TYMLOS’ share in the U.S. anabolic osteoporosis market increased to an average of 19% in the second quarter from [...]

Albireo Reports Second Quarter 2018 Financial Results

07/08/2018 - 13:30

A4250 Phase 3 trial in PFIC underway A4250 granted rare pediatric disease designation, eligible to apply for priority review voucher Management to host conference call and webcast today at 8:30 a.m. EDT BOSTON, Aug. 07 [...]